Profund Advisors LLC grew its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 6.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 85,351 shares of the pharmacy operator’s stock after acquiring an additional 5,389 shares during the period. Profund Advisors LLC’s holdings in Walgreens Boots Alliance were worth $6,684,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Choate Investment Advisors lifted its position in shares of Walgreens Boots Alliance by 0.7% in the second quarter. Choate Investment Advisors now owns 33,372 shares of the pharmacy operator’s stock worth $2,613,000 after buying an additional 243 shares in the last quarter. Stevens Capital Management LP lifted its position in shares of Walgreens Boots Alliance by 24.5% in the second quarter. Stevens Capital Management LP now owns 93,365 shares of the pharmacy operator’s stock worth $7,311,000 after buying an additional 18,378 shares in the last quarter. BlueMountain Capital Management LLC lifted its position in shares of Walgreens Boots Alliance by 147.4% in the second quarter. BlueMountain Capital Management LLC now owns 34,380 shares of the pharmacy operator’s stock worth $2,692,000 after buying an additional 20,483 shares in the last quarter. Amalgamated Bank lifted its position in shares of Walgreens Boots Alliance by 71.9% in the second quarter. Amalgamated Bank now owns 105,495 shares of the pharmacy operator’s stock worth $8,261,000 after buying an additional 44,114 shares in the last quarter. Finally, Edmond DE Rothschild Holding S.A. lifted its position in shares of Walgreens Boots Alliance by 3.6% in the second quarter. Edmond DE Rothschild Holding S.A. now owns 6,700 shares of the pharmacy operator’s stock worth $524,000 after buying an additional 235 shares in the last quarter. Institutional investors and hedge funds own 63.58% of the company’s stock.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at $70.37 on Tuesday. Walgreens Boots Alliance, Inc. has a 52 week low of $63.82 and a 52 week high of $88.00. The stock has a market capitalization of $71,667.88, a P/E ratio of 13.92, a P/E/G ratio of 1.26 and a beta of 1.20. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The company had revenue of $30.15 billion for the quarter, compared to analysts’ expectations of $29.93 billion. During the same quarter in the prior year, the firm earned $1.07 earnings per share. Walgreens Boots Alliance’s revenue was up 5.3% compared to the same quarter last year. analysts expect that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be paid a $0.40 dividend. The ex-dividend date is Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.27%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 42.33%.

Walgreens Boots Alliance announced that its board has authorized a share repurchase program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

In related news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director John Anthony Lederer acquired 20,000 shares of the company’s stock in a transaction that occurred on Thursday, October 26th. The stock was purchased at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the purchase, the director now owns 50,000 shares of the company’s stock, valued at $3,350,000. The disclosure for this purchase can be found here. 13.50% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: This piece was published by Daily Political and is the sole property of of Daily Political. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://www.dailypolitical.com/2017/11/14/walgreens-boots-alliance-inc-wba-shares-bought-by-profund-advisors-llc.html.

A number of research firms recently commented on WBA. Jefferies Group LLC set a $93.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Sunday, October 29th. Needham & Company LLC reiterated a “buy” rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a research report on Thursday, October 12th. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday. Zacks Investment Research upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Thursday, October 5th. Finally, Robert W. Baird reiterated an “outperform” rating and issued a $80.00 target price (down from $90.00) on shares of Walgreens Boots Alliance in a research report on Thursday, October 19th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $87.63.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.